Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Haematologica
|
October 30, 2016
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
John O Mascarenhas, Moshe Talpaz, Vikas Gupta, et al.
JCI Insight
|
February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes
Lynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Vital and Health Statistics. Series 2, Data Evaluation and Methods Research
|
February 5, 2021
An Investigation of Nonresponse Bias and Survey Location Variability in the 2017-2018 National Health and Nutrition Examination Survey
Tala H I Fakhouri, Crescent B Martin, Te-Ching Chen, et al.
BMC Cancer
|
July 25, 2024
Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study
Andrea Necchi, Michiel S Van der Heijden, Dmytro Trukhin, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Herbert I Hurwitz, Nikhil Uppal, Stephanie A Wagner, et al.
Physical Review Letters
|
November 30, 2025
Fingerprints of Triaxiality in the Charge Radii of Neutron-Rich Ruthenium
Bernhard Maass, Wouter Ryssens, Kristian König, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2011
A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumors
Francesco Atzori, Josep Tabernero, Andrés Cervantes, et al.
Arthritis and Rheumatism
|
September 1, 2007
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
Nicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
Cell Stem Cell
|
June 18, 2013
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics
Sibgat Choudhury, Vanessa Almendro, Vanessa F Merino, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Haematologica
|
October 30, 2016
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
John O Mascarenhas, Moshe Talpaz, Vikas Gupta, et al.
JCI Insight
|
February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes
Lynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Vital and Health Statistics. Series 2, Data Evaluation and Methods Research
|
February 5, 2021
An Investigation of Nonresponse Bias and Survey Location Variability in the 2017-2018 National Health and Nutrition Examination Survey
Tala H I Fakhouri, Crescent B Martin, Te-Ching Chen, et al.
BMC Cancer
|
July 25, 2024
Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study
Andrea Necchi, Michiel S Van der Heijden, Dmytro Trukhin, et al.
Journal for Immunotherapy of Cancer
|
October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors
Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2015
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Herbert I Hurwitz, Nikhil Uppal, Stephanie A Wagner, et al.
Physical Review Letters
|
November 30, 2025
Fingerprints of Triaxiality in the Charge Radii of Neutron-Rich Ruthenium
Bernhard Maass, Wouter Ryssens, Kristian König, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2011
A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumors
Francesco Atzori, Josep Tabernero, Andrés Cervantes, et al.
Arthritis and Rheumatism
|
September 1, 2007
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
Nicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
Cell Stem Cell
|
June 18, 2013
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics
Sibgat Choudhury, Vanessa Almendro, Vanessa F Merino, et al.
Page
of 8